Investor Presentaiton slide image

Investor Presentaiton

Innovation and Globalization are Our Key Strategies Innovation Develop potentially global first-in- class products + Globalization Develop and sell Innovent products globally Innovent 信达生物制药 A premier global biopharmaceutical company Build on robust pipeline ● Focus on unmet patients' needs Global leading R&D capabilities and cutting-edge technologies ● Collaboration with leading global biopharmaceutical companies Expand Innovent's in-house R&D and commercial arms globally ● Expand manufacturing capacity globally By 2030, more commercialized products, including first-in-class products launched globally Innovent Confidential Copyright©2021 Innovent Biologics 31
View entire presentation